Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to examine whether a stratified medication review performed in patients at highest risk of experiencing medication errors have impact on numbers of medication errrors during hospitalization.


Clinical Trial Description

Acutely admitted medical patients will be included after admission. After inclusion and randomization the patients will be risk stratified with an existing algorithm according to risk of medication error. The patients in the intervention group will receive a medication review performed by a clinical pharmacist if they are in high medication error risk. Patients in highest medication error risk will recieve a medication review performed by a clinical pharmacologist. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms

  • Patients in Highest Medication Error Risk

NCT number NCT01819974
Study type Interventional
Source University of Aarhus
Contact Dorthe K Bonnerup, Msc
Phone +4560472921
Email dortbonn@rm.dk
Status Recruiting
Phase N/A
Start date April 2013
Completion date May 2014